Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
anagrelide
i
Other names:
SPD-422, KRN654, BL4162A, BMY2653801, KRN 654, SPD422, BL 4162A, BMY 2653801, SPD 422, BL-4162A, BMY-2653801, KRN-654
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Generic mfg.
Drug class:
PLA2 inhibitor, PDE3 inhibitor
Related drugs:
‹
hydroxychloroquine (7)
hydroxychloroquine MDT (0)
icosapent ethyl (0)
ibudilast (0)
hydroxychloroquine (7)
hydroxychloroquine MDT (0)
icosapent ethyl (0)
ibudilast (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
PDE3A overexpression
Acute Myelogenous Leukemia
PDE3A overexpression
Acute Myelogenous Leukemia
idarubicin hydrochloride + anagrelide
Sensitive: D – Preclinical
idarubicin hydrochloride + anagrelide
Sensitive
:
D
idarubicin hydrochloride + anagrelide
Sensitive: D – Preclinical
idarubicin hydrochloride + anagrelide
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.